BCBS North Dakota · Weight Loss

BCBS North Dakota coverage for Zepbound (Weight Loss)

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

Age 18 and older
BMI of 30 or higher
BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, OSA, and CVD)
6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Adult obesity without comorbidity

All of:

BMI >= 30 kg/m2
Inadequate response to comprehensive lifestyle intervention program

Adult overweight with comorbidity

All of:

BMI >= 27 kg/m2
Inadequate response to comprehensive lifestyle intervention program

Plus any one of:

Hypertension
Type 2 diabetes
Dyslipidemia
Obstructive sleep apnea
Cardiovascular disease
Other weight-related comorbid condition

Documentation to bring

Documentation of BMI >= 30 kg/m2 or >= 27 kg/m2 with at least one weight-related comorbidity
Documentation of prior comprehensive lifestyle intervention program attempt or reason it is not feasible
Documentation of weight-related comorbid condition if BMI is 27-29.9 kg/m2

Approval and renewal

To renew, the plan looks for at least 5% weight loss from the starting weight, Per referenced guidelines, if weight loss >= 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued, and at least 12 weeks on therapy before the first renewal. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

Coadministration with other tirzepatide-containing products is not recommended
Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: Zepbound is available as subcutaneous injection vial and KwikPen formulations. FDA indication is for adults only. Full PA criteria details beyond FDA indication summary and referenced guidelines are not enumerated in the provided document text.

Policy effective April 20, 2026 · verified June 2, 2026 · source: ND_Weight_Management_PAQL_ProgSum.pdf

ACA Marketplace

Covered with requirements

What you need to qualify

Age 18 and older
BMI of 30 or higher
BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, OSA, and CVD)
6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Adult obesity without comorbidity

All of:

BMI >= 30 kg/m2
Inadequate response to comprehensive lifestyle intervention program

Adult overweight with comorbidity

All of:

BMI >= 27 kg/m2
Inadequate response to comprehensive lifestyle intervention program

Plus any one of:

Hypertension
Type 2 diabetes
Dyslipidemia
Obstructive sleep apnea
Cardiovascular disease
Other weight-related comorbid condition

Documentation to bring

Documentation of BMI >= 30 kg/m2 or >= 27 kg/m2 with at least one weight-related comorbidity
Documentation of prior comprehensive lifestyle intervention program attempt or reason it is not feasible
Documentation of weight-related comorbid condition if BMI is 27-29.9 kg/m2

Approval and renewal

To renew, the plan looks for at least 5% weight loss from the starting weight, Per referenced guidelines, if weight loss >= 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued, and at least 12 weeks on therapy before the first renewal. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

Coadministration with other tirzepatide-containing products is not recommended
Coadministration with any GLP-1 receptor agonist is not recommended

Policy effective April 20, 2026 · verified June 2, 2026 · source: ND_Weight_Management_PAQL_ProgSum.pdf

All Zepbound policies under BCBS North Dakota · Check your card